| NCT ID | NCT04900558 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Florence |
| Condition | Bladder Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2021-04-29 |
| Primary Completion | 2031-02-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2021-04-29 with a primary completion date of 2031-02-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Currently, in the treatment of bladder cancer the use of robotics has entered in clinical practice, therefor robotic radical cystectomy with or without reconstruction is offered to patients during counseling procedures, if deemed appropriate and possible. The aim of the study is therefore the long-term evaluation of the peri-post-operative, oncological and functional results of patients undergoing radical cystectomy, both with an open and robotic approach. This study will thus help to clarify the actual impact of robotic surgery
Eligibility Criteria
Inclusion Criteria: * Age major or equal 18 years * Patients who will undergo radical cystectomy * Consent to participate Exclusion Criteria: * Absence of willingness to participate * Further refusal to participate to the study
Contact & Investigator
Arcangelo Sebastianelli, MD
PRINCIPAL INVESTIGATOR
Careggi Hospital, University of Florence
Frequently Asked Questions
Who can join the NCT04900558 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Bladder Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04900558 currently recruiting?
Yes, NCT04900558 is actively recruiting participants. Contact the research team at simone.morselli.89@gmail.com for enrollment information.
Where is the NCT04900558 trial being conducted?
This trial is being conducted at Florence, Italy.
Who is sponsoring the NCT04900558 clinical trial?
NCT04900558 is sponsored by University of Florence. The principal investigator is Arcangelo Sebastianelli, MD at Careggi Hospital, University of Florence. The trial plans to enroll 500 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.